FIELD: medicine; neurology.
SUBSTANCE: invention is intended to predict the development of cognitive impairment in patients with concussion and mild brain contusion. The determination of laboratory indicators of type 1 T-helpers in peripheral blood, the soluble form of the CD40 ligand and IFNγ-inducible protein 10 in cerebrospinal fluid is performed. Based on the obtained indicators, the probability of development (P) of cognitive impairments is determined according to a given formula, and when P is greater than or equal to 0.50, the development of cognitive impairments is predicted.
EFFECT: method allows to prevent the formation of new neurological syndromes in the early and late periods after a traumatic brain injury and to optimize ongoing drug therapy by assessing the totality of the most significant indicators.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPMENT OF PURULENT-INFLAMMATORY COMPLICATIONS IN PATIENTS WITH CRANIO-BRAIN INJURY OF VARIOUS DEGREES OF SEVERITY | 2023 |
|
RU2798153C1 |
| METHOD OF PREDICTION OF DISEASE OUTCOMES IN PATIENTS WITH TRAUMATIC BRAIN INJURY OF VARIOUS SEVERITY (ITS VARIANTS) | 2023 |
|
RU2799834C1 |
| METHOD OF DIFFERENTIATION OF BRAIN CONCUSSION, AND MILD, MODERATE AND SEVERE BRAIN CONTUSION | 2023 |
|
RU2798182C1 |
| METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF BRAIN CONCUSSION AND BRAIN CONTUSION OF LIGHT DEGREE AT EARLY STAGE IN CHILDREN | 2003 |
|
RU2241225C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF BRAIN CONCUSSION AND LIGHT DEGREE BRAIN CONTUSION | 2001 |
|
RU2207572C1 |
| METHOD OF DIFFERENTIATING HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIS B AND AUTOIMMUNE LIVER INJURIES | 2018 |
|
RU2701723C1 |
| METHOD FOR PREDICTING THE BRAIN TRAUMA DISEASE DEVELOPMENT COURSE | 2001 |
|
RU2178179C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF LIGHT-DEGREE CONCUSSION AND BRUISE OF BRAIN IN CHILDREN IN ACUTE PERIOD | 2006 |
|
RU2306100C1 |
| METHOD FOR PREDICTING COMPLICATIONS IN TRAUMATIC BRAIN INJURY | 2017 |
|
RU2685552C2 |
| METHOD FOR DIFFERENTIATING CAUSES OF DEVELOPMENT OF INITIAL STAGE OF HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIDES B AND C | 2019 |
|
RU2759672C2 |
